Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
An effective vaccine is only the first step: the need to create and sustain demand for TB vaccinesFriday, August 9, 2024Acceptability, Acceptability and demand, Implementation strategies and feasibilityRead More
The full value of vaccine assessments concept—current opportunities and recommendationsFriday, August 9, 2024Availability, Policy and frameworksRead More
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: A scoping reviewFriday, August 9, 2024Acceptability, Acceptability and demand, Acceptability and demand, Accessibility, Implementation strategies and feasibility, Implementation strategies and feasibilityRead More
TB vaccine advocacy roadmapFriday, August 9, 2024Accessibility, Community engagement, Policy and frameworksRead More
An investment case for new tuberculosis vaccinesFriday, August 9, 2024Availability, Policy and frameworksRead More
WHO evidence considerations for vaccine policy development for tuberculosis vaccines intended for adults and adolescentsFriday, August 9, 2024Availability, Policy and frameworksRead More
